Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Microbes Infect ; 15(6-7): 440-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23421980

ABSTRACT

Erythritol is a four-carbon sugar preferentially utilized by Brucella spp. The presence of erythritol in the placentas of goats, cows, and pigs has been used to explain the localization of Brucella to these sites and the subsequent accumulation of large amounts of bacteria, eventually leading to abortion. Here we show that Brucella melitensis will also localize to an artificial site of erythritol within a mouse, providing a potential model system to study the pathogenesis of Brucella abortion. Immunohistological staining of the sites of erythritol within infected mice indicated a higher than expected proportion of extracellular bacteria. Ensuing experiments suggested intracellular B. melitensis was unable to replicate within macrophages in the presence of erythritol and that erythritol was able to reach the site of intracellular bacteria. The intracellular inhibition of growth was found to encourage the bacteria to replicate extracellularly rather than intracellularly, a particularly interesting development in Brucella pathogenesis. To determine the effect of erythritol on expression of B. melitensis genes, bacteria grown either with or without erythritol were analyzed by microarray. Two major virulence pathways were up-regulated in response to exposure to erythritol (the type IV secretion system VirB and flagellar proteins), suggesting a role for erythritol in virulence.


Subject(s)
Brucella melitensis/metabolism , Brucella melitensis/pathogenicity , Brucellosis/microbiology , Brucellosis/pathology , Erythritol/metabolism , Gene Expression Regulation, Bacterial/drug effects , Virulence Factors/biosynthesis , Animals , Disease Models, Animal , Gene Expression Profiling , Macrophages/microbiology , Mice , Microarray Analysis
2.
Vet Parasitol ; 148(3-4): 219-30, 2007 Sep 30.
Article in English | MEDLINE | ID: mdl-17651896

ABSTRACT

Neospora caninum, an obligate intracellular protozoan parasite, is the causative agent of bovine neosporosis, an important disease affecting the reproductive performance of cattle worldwide. Currently there is no effective vaccine available to prevent N. caninum infection in cattle. In this study, we examined the feasibility of developing a live, recombinant N. caninum vaccine using Brucella abortus vaccine strain RB51 as the expression and delivery vector. We generated two recombinant RB51 strains each expressing SRS2 (RB51/SRS2) or GRA7 (RB51/GRA7) antigens of N. caninum. BALB/c mice immunized by single intraperitoneal inoculation of the recombinant RB51 strains developed IgG antibodies specific to the respective N. caninum antigen. In vitro stimulation of splenocytes from the vaccinated mice with specific antigen resulted in the production of interferon-gamma, but not IL-5 or IL-10, suggesting the development of a Th1 type immune response. Upon challenge with N. caninum tachyzoites, mice vaccinated with strain RB51/SRS2, but not RB51/GRA7, showed significant resistance to cerebral infection when compared to the RB51 vaccinated mice, as determined by the tissue parasite load using a real-time quantitative TaqMan assay. Interestingly, mice vaccinated with either strain RB51 or RB51/GRA7 also contained significantly lower parasite burden in their brains compared to those inoculated with saline. Mice vaccinated with strain RB51/SRS2 or RB51/GRA7 were protected to the same extent as the strain RB51 vaccinated mice against challenge with B. abortus virulent strain 2308. These results suggest that a recombinant RB51 strain expressing an appropriate protective antigen(s), such as SRS2 of N. caninum, can confer protection against both neosporosis and brucellosis.


Subject(s)
Antigens, Protozoan/immunology , Antigens, Surface/immunology , Brucella Vaccine/immunology , Brucella abortus/genetics , Coccidiosis/immunology , Neospora/immunology , Protozoan Proteins/immunology , Protozoan Vaccines/immunology , Animals , Antibodies, Protozoan/blood , Antigens, Protozoan/genetics , Antigens, Surface/genetics , Coccidiosis/parasitology , Coccidiosis/prevention & control , Escherichia coli/genetics , Female , Interferon-gamma/metabolism , Mice , Mice, Inbred BALB C , Neospora/genetics , Protozoan Proteins/genetics , Random Allocation , Recombinant Proteins/immunology , Spleen/cytology , Spleen/immunology , Vaccines, DNA/immunology
3.
Int J Parasitol ; 37(13): 1521-9, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17568587

ABSTRACT

Bovine abortions caused by the intracellular protozoal parasite Neospora caninum are a major concern to cattle industries worldwide. A strong Th1 immune response is required for protection against N. caninum. Brucella abortus strain RB51 is currently used as a live, attenuated vaccine against bovine brucellosis. Strain RB51 can also be used as an expression vector for heterologous protein expression. In this study, putative protective antigens of N. caninum MIC1, MIC3, GRA2, GRA6 and SRS2, were expressed individually in B. abortus strain RB51. The ability of each of the recombinant RB51 strains to induce N. caninum-specific immunity was assessed in C57BL/6 mice. Mice were immunised by two i.p. inoculations, 4 weeks apart. Five weeks after the second immunisation, spleen cells from the vaccinated mice secreted high levels of IFN-gamma and IL-10 upon in vitro stimulation with N. caninum whole cell lysate antigens. N. caninum-specific antibodies of both IgG1 and IgG2a subtypes were detected in the serum of the vaccinated mice. Mice in the vaccinated and control groups were challenged with 2 x 10(7)N. caninum tachyzoites i.p. and observed for 28 days after vaccination. All unvaccinated control mice died within 7 days. Mice in the MIC1 and GRA6 vaccine groups were completely protected while the mice in the SRS2, GRA2 and MIC3 vaccinated groups were partially protected and experienced 10-50% mortality. The non-recombinant RB51 vector control group experienced an average protection of 69%. These results suggest that expression of protective antigens of N. caninum in B. abortus strain RB51 is a novel approach towards the development of a multivalent vaccine against brucellosis and neosporosis.


Subject(s)
Antigens, Protozoan/immunology , Brucella Vaccine/immunology , Brucella abortus/immunology , Neospora/immunology , Animals , Female , Immunoglobulin G/blood , Interferon-gamma/metabolism , Interleukin-10/metabolism , Mice , Mice, Inbred C57BL , Random Allocation , Survival Analysis
4.
Int J Parasitol ; 37(13): 1531-8, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17575983

ABSTRACT

Bovine abortions caused by the apicomplexan parasite Neospora caninum have been responsible for severe economic losses to the cattle industry. Infected cows either experience abortion or transmit the parasite transplacentally at a rate of up to 95%. Neospora caninum vaccines that can prevent vertical transmission and ensure disruption in the life cycle of the parasite greatly aid in the management of neosporosis in the cattle industry. Brucella abortus strain RB51, a commercially available vaccine for bovine brucellosis, can also be used as a vector to express plasmid-encoded proteins from other pathogens. Neospora caninum protective antigens MIC1, MIC3, GRA2, GRA6 and SRS2 were expressed in strain RB51. Female C57BL/6 mice were vaccinated with a recombinant strain RB51 expressing N. caninum antigen or irradiated tachyzoites, boosted 4 weeks later and then bred. Antigen-specific IgG, IFN-gamma and IL-10 were detected in vaccinated pregnant mice. Vaccinated mice were challenged with 5 x 10(6)N. caninum tachyzoites between days 11-13 of pregnancy. Brain tissue was collected from pups 3 weeks after birth and examined for the presence of N. caninum by real-time PCR. The RB51-MIC3, RB51-GRA6, irradiated tachyzoite vaccine, pooled strain RB51-Neospora vaccine, RB51-MIC1 and RB51-SRS2 vaccines elicited approximately 6-38% protection against vertical transmission. However, the differences in parasite burden in brain tissue of pups from the control and vaccinated groups were highly significant for all groups. Thus, B. abortus strain RB51 expressing the specific N. caninum antigens induced substantial protection against vertical transmission of N. caninum in mice.


Subject(s)
Antigens, Protozoan/immunology , Brucella Vaccine/immunology , Brucella abortus/immunology , Brucellosis/transmission , Infectious Disease Transmission, Vertical/prevention & control , Neospora/immunology , Animals , Brain/parasitology , Female , Immunoglobulin G/blood , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-4/metabolism , Mice , Mice, Inbred C57BL , Pregnancy , Survival Analysis , Th1 Cells/immunology
5.
Clin Diagn Lab Immunol ; 12(12): 1429-36, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16339067

ABSTRACT

Brucella abortus strain RB51 is an attenuated rough mutant used as the live vaccine against bovine brucellosis in the United States and other countries. We previously reported the development of strain RB51 as a bacterial vaccine vector for inducing Th1-type immune responses against heterologous proteins. Because safety concerns may preclude the use of strain RB51-based recombinant live vaccines, we explored the ability of a gamma-irradiated recombinant RB51 strain to induce heterologous antigen-specific immune responses in BALB/c mice. Exposure of strain RB51G/LacZ expressing Escherichia coli beta-galactosidase to a minimum of 300 kilorads of gamma radiation resulted in complete loss of replicative ability. These bacteria, however, remained metabolically active and continued to synthesize beta-galactosidase. A single intraperitoneal inoculation of mice with 10(9) CFU equivalents of gamma-irradiated, but not heat-killed, RB51G/LacZ induced a beta-galactosidase-specific Th1-type immune response. Though no obvious differences were detected in immune responses to B. abortus-specific antigens, mice vaccinated with gamma-irradiated, but not heat-killed, RB51G/LacZ developed significant protection against challenge with virulent B. abortus. In vitro experiments indicated that gamma-irradiated and heat-killed RB51G/LacZ induced maturation of dendritic cells; however, stimulation with gamma-irradiated bacteria resulted in more interleukin-12 secretion. These results suggest that recombinant RB51 strains exposed to an appropriate minimum dose of gamma radiation are unable to replicate but retain their ability to stimulate Th1 immune responses against the heterologous antigens and confer protection against B. abortus challenge in mice.


Subject(s)
Brucella Vaccine/immunology , Brucella abortus/immunology , Th1 Cells/immunology , Animals , Brucella abortus/genetics , Brucella abortus/physiology , Brucellosis/prevention & control , Cytokines/biosynthesis , Dendritic Cells/metabolism , Escherichia coli , Gamma Rays , Genetic Vectors , Immunoglobulin G/blood , Mice , Mice, Inbred BALB C , Radiation Dosage , Virus Replication/radiation effects
6.
Vet Microbiol ; 102(3-4): 237-45, 2004 Sep 08.
Article in English | MEDLINE | ID: mdl-15327798

ABSTRACT

Brucella abortus strain RB51 is an attenuated rough strain, currently being used as the official live vaccine for bovine brucellosis in the USA and several other countries. In strain RB51, the wboA gene, encoding a glycosyltransferase required for the O-side chain synthesis, is disrupted by an IS711 element. Recently, we have demonstrated that strain RB51WboA, RB51 complemented with a functional wboA gene, remains rough but expresses low quantities of O-side chain in the cytoplasm. Mice vaccinated with strain RB51WboA develop greatly enhanced resistance against challenge with B. abortus virulent strain 2308. We have also demonstrated that overexpression of Cu/Zn superoxide dismutase (SOD) in strain RB51 (RB51SOD) significantly increases its vaccine efficacy against strain 2308 challenge. In this study, we constructed a new recombinant strain, RB51SOD/WboA, that over expresses SOD with simultaneous expression of O-side chain in the cytoplasm. We tested the vaccine potential of strains RB51SOD, RB51WboA, RB51SOD/WboA against challenge with virulent Brucella melitensis 16M and B. abortus 2308 in mice. In comparison with strain RB51, strain RB51SOD induced better protection against strain 2308, but not strain 16M, challenge. Similar to strain RB51WboA, vaccination with strain RB51SOD/WboA resulted in complete protection of the mice from infection with strain 2308. When challenged with strain 16M, mice vaccinated with either strain RB51WboA or strain RB51SOD/WboA were significantly better protected than those vaccinated with strain RB51 or RB51SOD. These results suggest that strains RB51WboA and RB51SOD/WboA are good vaccine candidates for inducing enhanced protection against B. melitensis infection.


Subject(s)
Brucella Vaccine/immunology , Brucella abortus/immunology , Brucella melitensis , Brucellosis/veterinary , Animals , Bacterial Vaccines , Brucella Vaccine/genetics , Brucella abortus/genetics , Brucella melitensis/genetics , Brucella melitensis/immunology , Brucella melitensis/pathogenicity , Brucellosis/microbiology , Brucellosis/prevention & control , Cattle , Genes, Bacterial , Glycosyltransferases/genetics , Interferon-gamma/biosynthesis , Mice , O Antigens/biosynthesis , O Antigens/genetics , Phenotype , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Serologic Tests/veterinary , Superoxide Dismutase/genetics , Treatment Outcome , Vaccines, Attenuated/immunology , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...